Volume 19, issue 4, Avril 2012

Éditorial

Immunosuppressive therapy and cancers in inflammatory bowel disease or how to take into account the benefit-risk ratio in our clinical practice? (p.227-9)
Laurent Peyrin-Biroulet
Free Access

Mini-revue

Radioembolization of primary and secondary liver tumors (p.231-8)
Olivier Dubreuil, Aziz Zaanan, Isabelle Trouilloud, Marc Sapoval, Olivier Pellerin, Sameh Awad, Nadia Ghazzar, Céline Lepère, Philippe Rougier, Julien Taieb
Free Access

MSI colon cancer: is adjuvant therapy warranted? (p.242-7)
Aziz Zaanan, Olivier Dubreuil, Isabelle Trouilloud, Pierre Laurent-Puig, Julien Taieb
Free Access

Evolution of practices and factual results of liver transplantation for alcoholic liver disease (p.248-53)
Amélie Cannesson, Guillaume Lassailly, Emmanuel Boleslawski, Alexandre Louvet, Philippe Mathurin, François René Pruvot, Sébastien Dharancy
Free Access

Clinical implications of diabetes mellitus in cirrhosis (p.254-62)
Pauline Houssel, Richard Moreau, Laure Elkrief
Free Access

Dyschezia: from diagnostic to treatment (p.263-71)
Véronique Vitton, Henri Damon, Jean-Luc Faucheron
Free Access

Screening of biliary and liver diseases in inflammatory bowel disease. Consequences on the therapeutic management (p.272-9)
Stéphane Nancey, Gilles Boschetti, Bernard Flourié
Free Access

Concepts et Pratique

Acute severe alcoholic hepatitis: good news from France! (p.280-4)
Alexandre Pariente
Free Access

Fecal tranplantation: new therapy for recurrent Clostridium difficile infection? (p.285-8)
Frédérique Maire
Free Access

Infos-PRO

Une loi de circonstance (p.289-90)
Philippe Godeberge
Free Access

Agenda

Agenda (p.291-2)

Free Access

Injections de rappel

Injections de rappel (p.293-4)

Free Access